An exploration of selected variables as a predictor of COVID-19 vaccination rollouts: A correlational study
Ebtisam A. Benomran, Thabet A. M. Nagah, Maria Cristina Arboleda-Tinay, Naseeb A. Gusbi, Taha El Jali
Abstract
Coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus. The study aimed to determine the variables that would predict the vaccination rollouts. The objective of this study was to determine the acceptance of the COVID-19 vaccine among the general adult population in Libya and assess its determinants. Specifically, it aims to answer the following questions: What are the variables that would predict the vaccination rollouts, in terms of knowledge about the vaccine, exposure to coronavirus 2? What is the respondent's level of acceptance of COVID-19 vaccination? Is there a significant relationship between the predictors of vaccination turnouts and the level of acceptance of COVID-19 vaccination? The findings that the researcher was able to extract from the study were: The frequency and percentage of the Knowledge as a predictor of vaccination turnouts is 94.1% for YES and 5.8% for NO. In terms of exposure to the coronavirus, those who tested positive for COVID-19 yielded a result of 29.4%, and those who tested negative with 70.5%. Detailed analysis of the results reveals that the level of acceptance of respondents to COVID-19 vaccination is 52.9% for YES, they will avail, and 47.0% for NO, they would not want to avail. Both determinants, the knowledge and exposure to coronavirus, yielded a positive, strong relationship with the level of acceptance of COVID-19 vaccination.
Keywords
References
- Chauhan S. Comprehensive review of coronavirus disease 2019 (COVID-19). Biomedical Journal. 2020; 43(4): 334-340. doi: 10.1016/j.bj.2020.05.023
- Caldaria A, Conforti C, Di Meo N, Dianzani C, Jafferany M, Lotti T, Zalaudek I, Giuffrida R. COVID-19 and SARS: Differences and similarities. Dermatologic Therapy. 2020; 33(4): e13395. doi: 10.1111/dth.13395
- Eurosurveillance editorial team. Note from the editors: The World Health Organization declares novel coronavirus (2019-nCoV) a sixth public health emergency of international concern. Eurosurveillance. 2020; 25(5): 200131e. doi: 10.2807/1560-7917.ES.2020.25.5.200131e
- Neser FR, Ibsheesh FA, Alhaj AM, Alghazal KA, Ibrahem KM, et al. Bouder OM. Knowledge, performance, and awareness towards the use of disinfectant and hand sanitizers during the COVID-19 pandemic: A questionnaire-based survey. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2024; 4(2): 55-63. doi: 10.5281/ zenodo.11479336
- Feikin DR, Higdon MM, Abu-Raddad LJ, Andrews N, Araos R, Goldberg Y, et al. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression. Lancet. 2022; 399(10328): 924-944. doi: 10.1016/S0140-6736(22)00152-0. Erratum in: The Lancet. 2024; 404(10455): e3. doi: 10.1016/S0140-6736(22)00428-7. Erratum in: The Lancet. 2023; 401(10377): 644. doi: 10.1016/S0140-6736(23)00331-8
- Mbenah AJ, Magwe EA. Vaccination coverage and timeliness among children aged 12-23 months in Kongwa District, Dodoma, Tanzania. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2025; 5(4): 1-10. doi: 10.5281/zenodo.17220401
- Nainu F, Abidin RS, Bahar MA, Frediansyah A, Emran TB, Rabaan AA, et al. SARS-CoV-2 reinfection and implications for vaccine development. Human Vaccines and Immunotherapeutics. 2020; 16(12): 3061-3073. doi: 10.1080/21645515.2020.1830683
- Mohseni Afshar Z, Barary M, Hosseinzadeh R, Alijanpour A, Hosseinzadeh D, Ebrahimpour S, et al. Breakthrough SARS-CoV-2 infections after vaccination: A critical review. Human Vaccines and Immuno-therapeutics. 2022; 18(5): 2051412. doi: 10.1080/21645515.2022.2051412
- Alhaddad FE, Abuleid KM. Evaluation of adverse effects of AstraZeneca COVID-19 vaccine after the first dose in Libyan adults: a cross-sectional study. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2022; 2(4): 65-69. doi: 10.5281/zenodo.7479778
- Alzawam MS, Hasan FO. Factors associated with the inflammatory immune response induced by COVID-19 vaccines among adults. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2023; 3(1): 12-18. doi: 10.5281/zenodo.7771333
- Omran EAA, Amal MA, Alshebani AMA, Almajdoub OH. Potential risk factors for mortality in patients with COVID-19: A retrospective study. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2022; 2(1): 37-43. doi: 10.5281/zenodo.6399474
- Paul SK. Assessment of knowledge and attitude of adverse drug reactions among healthcare professionals in Bangladesh. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2025; 5(2): 70-78. doi: 10.5281/ zenodo.15275065
- Sharif SI, Sharif RS, Jabri RA, Shriki RA, Abduelkarem AR. Evaluation of students’ perception and attitudes toward switching from in-class to online teaching in the era of COVID-19. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2024; 4(1): 12-21. doi: 10.5281/zenodo.10565075
- Alssageer MA, Khattab BF, Bakouri AH. Physicians' attitudes, expectations, and experiences about clinical pharmacists and the barriers they face in developing a collaborative relationship with them. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2024; 4 (3): 27-38. doi: 10.5281/zenodo.13324209
- De Francia S, Chiara F, Allegra S. COVID-19 Prevention and Treatment. Life (Basel). 2023; 13(3): 834. doi: 10.3390/life13030834
- Brown KA, Buchan SA, Chan AK, Costa A, Daneman N, Garber G, et al. Association between delayed outbreak identification and SARS-CoV-2 infection and mortality among long-term care home residents, Ontario, Canada, March to November 2020: A cohort study. Eurosurveillance. 2024; 29(41): 2300719. doi: 10.2807/1560-7917
- Tana C, Moffa L, Falasca K, Vecchiet J, Tana M, Mantini C, Ricci F, Ticinesi A, Meschi T, Cipollone F, Giamberardino MA. Approach to COVID-19 in older adults and indications for improving the outcomes. Annals of Medicine. 2023; 55(2): 2265298. doi: 10.1080/07853890.2023.2265298
- Chen H, Shi L, Zhang Y, Wang X, Jiao J, Yang M, Sun G. Response to the COVID-19 pandemic: Comparison of strategies in six countries. Frontiers in Public Health. 2021; 9: 708496. doi: 10.3389/fpubh.2021.708496
- Taeb ST, Alamory MM, Alamamy ZM, Nafae SSH. Assessing the readiness of community pharmacists in Libya for vaccine administration: Barriers and opportunities. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2025; 5(1): 65-74. doi: 10.5281/zenodo.14695845
- Fisker AB, Thysen SM. Implementation and assessment of vaccination programmes: the importance of vaccination sequence for overall health outcomes. Human Vaccines and Immunotherapeutics. 2018; 14(12): 2900-2903. doi: 10.1080/21645515.2018.1496771
- Godbole S, Diwan V, Das S, Reddy MM, Kalyanasundaram M, Rajendran D, et al. Facilitators and barriers to the uptake of COVID-19 vaccine precaution dose among the adult population: qualitative analysis across six different states of India. Frontiers in Public Health. 2024; 11: 1293600. doi: 10.3389/fpubh.2023.1293600
Submitted date:
03/09/2026
Reviewed date:
05/20/2026
Accepted date:
05/29/2026
Publication date:
05/27/2026
